Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhui Chen

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 21, 2017
Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatmentSongliang Wu, Yu Sun, Yi Hu, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTORTao Yu, Ning Li, Chengde Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver diseaseJianfeng Mou, Songliang Wu, Zhi Luo, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2024
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitorZhaobing Xu, Yingchun Liu, Baohui Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infectionYanbin Hu, Fei Sun, Qiang Yuan, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-<i>c</i>]pyrimidines as Capsid Assembly Inhibitors for HBV TreatmentXiaolin Li, Kai Zhou, Haiying He, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMDPeng Li, Jun Yu, Fei Hao, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2016
Design, synthesis, and biological evaluation of anti-EV71 agentsPeng Li, Bailing Yang, Fei Hao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Non-invasive assessment of microcirculatory resistance by coronary computed tomography angiographyDan Deng, Ping Zhu, Xiaolong Qu, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|February 21, 2017
Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatmentSongliang Wu, Yu Sun, Yi Hu, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTORTao Yu, Ning Li, Chengde Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver diseaseJianfeng Mou, Songliang Wu, Zhi Luo, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2024
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitorZhaobing Xu, Yingchun Liu, Baohui Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infectionYanbin Hu, Fei Sun, Qiang Yuan, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-<i>c</i>]pyrimidines as Capsid Assembly Inhibitors for HBV TreatmentXiaolin Li, Kai Zhou, Haiying He, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMDPeng Li, Jun Yu, Fei Hao, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2016
Design, synthesis, and biological evaluation of anti-EV71 agentsPeng Li, Bailing Yang, Fei Hao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Non-invasive assessment of microcirculatory resistance by coronary computed tomography angiographyDan Deng, Ping Zhu, Xiaolong Qu, et al.
Pageof 12